Pharmacoinformatics and Molecular Docking studies reveal potential novel compounds against Schizophrenia by target SYN II.

CONCLUSION: It was proposed that Aripiprazole drug and scrutinized compounds have strong binding affinities among the other selected drugs. The reported compounds may use for further analyses in the drug discovery processes and it has been identified as a good human intestinal absorption and non-carcinogenic. The present study provides the structural insights which may be used for further understating of the Schizophrenia therapeutic purposes by targeting SYN II and others inhibitors haunting. PMID: 29436999 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29436999?dopt=Abstract

Source: Combinatorial Chemistry and High Throughput Screening - February 12, 2018 Category: Chemistry Authors: Tahir RA, Sehgal SA Tags: Comb Chem High Throughput Screen Source Type: research